|CONSUMER LAW GROUP has launched a national class action lawsuit against the makers of the weight-loss drug Meridia and the generic equivalent (Sibutramine), manufactured by Abbott Laboratories and Apotex, on behalf of individuals who have suffered from an adverse cardiovascular event.
Adverse cardiovascular events caused by the weight-loss drug Meridia or the generic equivalent (Sibutramine), includes the following symptoms:
• Heart Attack
• Intermittent cramping
• Chest pains
• Other heart-related events
To post a comment, please visit our blog at www.meridiaclassaction.blogspot.com
The class action lawsuit identifies the group of affected persons as:
All persons residing in Canada who have taken and/or purchased the drug MERIDIA or its generic equivalent (Sibutramine Hydrochloride Monohydrate) since December 28th 2000 and their successors, assigns, family members, and dependants, or any other group to be determined by the Court.
If you or a member of your family have used the weight-loss drug Meridia or the generic equivalent (Sibutramine) and suffered from adverse cardiovascular events or developed any other serious physical or psychological side effects or conditions while using the weight-loss drug Meridia or the generic equivalent (Sibutramine), and you wish more information on potential compensation or to be kept advised of the status of the Meridia Side Effects Class Action litigation or any resulting compensation from the Meridia Side Effects Lawsuit in Canada, Quebec or Ontario, please provide your contact information to our law firm using the below form.
IF YOU WISH TO JOIN THE CLASS ACTION OR TO SIMPLY GET MORE INFORMATION, PLEASE COMPLETE THE FORM BELOW. Please note that providing your information creates no financial obligation for you. You are not charged any fee or cost for joining this class action. Our law firm is paid a contingency fee from the compensation recovered, only if the class action is successful. All information contained in this transmission is confidential and Consumer Law Group agrees to protect this information against unauthorized use, publication or disclosure.